Tenet Healthcare Analyst Price Targets - Benzinga

Tenet Healthcare Corp

THCNYSE

Trade with Public

Trade with Public

$265.91

-0.89-0.33%

近くで: Aug 31, 5:00 PM EST

$265.91

N/A

時間外: 4:00 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Tenet Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tenet Healthcare (THC).

Price Target Range — 9 Quarters

Analyst Consensus — 19 Analysts

18Buy

1Hold

Consensus RatingOverweight# Analysts19Avg. Consensus PT$250Upside to Avg. PT-6.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 3, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$231→$281
Jul 28, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$270→$290
Jul 28, 2026	Baird	Michael Ha	PT Raise	Neutral	$210→$280
Jul 28, 2026	Guggenheim	Jason Cassorla	PT Raise	Buy	$242→$283
Jul 27, 2026	UBS	A.J. Rice	PT Raise	Buy	$288→$308
Jul 27, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$233→$263
Jul 27, 2026	Morgan Stanley	Craig Hettenbach	PT Raise	Overweight	$254→$274
Jul 27, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$236→$283
Jul 24, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$240→$271
Jul 20, 2026	Guggenheim	Jason Cassorla	PT Cut	Buy	$252→$242
Jul 13, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$213→$231
Jul 9, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$238→$240
Jun 22, 2026	TD Cowen	Ryan Langston	PT Cut	Buy	$242→$233
May 5, 2026	Barclays	Andrew Mok	PT Cut	Overweight	$257→$238
May 5, 2026	Baird	Michael Ha	PT Cut	Neutral	$245→$210
May 4, 2026	Stephens & Co.	Raj Kumar	PT Cut	Overweight	$275→$260
May 1, 2026	RBC Capital	Ben Hendrix	PT Cut	Outperform	$277→$236
May 1, 2026	Guggenheim	Jason Cassorla	PT Cut	Buy	$283→$252
May 1, 2026	Wells Fargo	Stephen Baxter	PT Cut	Overweight	$265→$213
May 1, 2026	Keybanc	Matthew Gillmor	PT Cut	Overweight	$250→$225

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $281

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $231 to $281.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $290

Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $270 to $290.

Benzinga Newsdesk

Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on top names. For a complete view, see analyst ratings page. See how others view these stocks.

Avi Kapoor

PRO
Baird Maintains Neutral on Tenet Healthcare, Raises Price Target to $280

Baird analyst Michael Ha maintains Tenet Healthcare (NYSE:THC) with a Neutral and raises the price target from $210 to $280.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $283

Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $242 to $283.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $308

UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $288 to $308.

Benzinga Newsdesk